To hear about similar clinical trials, please enter your email below
Trial Title:
Performance and Safety of MiWEndo-assisted Colonoscopy (MiWEndo II)
NCT ID:
NCT05988645
Condition:
Colorectal Cancer
Colorectal Polyp
Colorectal Adenoma
Colorectal Adenomatous Polyp
Colorectal Adenocarcinoma
Colorectal Neoplasms
Conditions: Official terms:
Colorectal Neoplasms
Adenoma
Adenomatous Polyps
Polyps
Conditions: Keywords:
microwave imaging
colonoscopy
early diagnosis
colorectal cancer screening
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Intervention model description:
Single Group Assignment Traditional safety and performance study, following a
single-center prospective and noncomparative.
Primary purpose:
Diagnostic
Masking:
None (Open Label)
Intervention:
Intervention type:
Device
Intervention name:
MiWEndo System
Description:
All colonoscopies will be performed with high-definition technology. The MiWEndo System
will be fitted to the tip of the endoscope before colonoscopy is started and connected to
the microwave processor unit. Endoscopies will be performed by experienced endoscopists
who will be previously trained on the use of the MiWEndo System. The MiWEndo Analyzer
will be managed by the assistant.
At the beginning of the extubation, the MiWEndo System will be turned on and the
endoscopist will put music headphones on (blind to the results of MiWEndo).
In case one of them identifies a polyp, the exploration will be stopped and check if it
has been detected by the alternative method as well. All the polyps will be resected and
sent to the Pathological Department for histological analysis following the usual
clinical practice. A stopwatch will be used to measure both total procedure time and
withdrawal time.
Arm group label:
MiWEndo + colonoscope
Summary:
The study involves the planned use of a new microwave-based device during colonoscopy
procedures in 50 patients to assess the performance and safety of its use for detection
of colorectal polyps and lack of normal clinical practice modification. The device is a
final design version, which has been previously tested in several preclinical studies
(including phantom studies, an ex vivo study with human tissues, and an in vivo study
with porcine model) and in a pilot study in humans (NCT05477836)
Detailed description:
This study is designed as a single-center prospective, non-comparative study in 50
patients, whereby data will be subject to an analytical description, rather than to a
statistical treatment (refer to Statistical design and analysis).
In this study the principal aims are to assess the performance and safety of the device
for the detection of colorectal polyps when used as an accessory to colonoscopy. Relevant
claims to verify in this study are that the device will detect in first instance polyps
not detected initially with the endoscopic image and can be used without ADEs, without
any change in the current clinical practice, as well as without any major difficulty by
the endoscopist, neither in the preparation nor in the use of the device during
exploration.
In addition, in the first phase of the study (n=15 patients), the study aims to gather
real clinical data with the use of the device to optimise the processing software that
will be key to demonstrate MiWEndo's performance on the second part of the study (n=35
patients).
Consequently, principal and secondary objectives of this investigation, are:
Principal objectives:
- To assess the performance of MiWEndo-assisted colonoscopy in the detection of
colorectal polyps.
- To assess the safety of MiWEndo-assisted colonoscopy.
Secondary objectives:
- To assess the feasibility of performing a complete colonoscopy using the MiWEndo
device.
- To assess the perception of difficulty by the endoscopist when the device is used.
- To assess the operator learning curve with MiWEndo-assisted colonoscopy to guide
future recommendations for training.
- To provide exploratory analysis of differences in MiWEndo-assisted colonoscopy in
different groups of patients to guide future RCT.
- To assess the patient's comfort.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Patients with previously resected polyps.
- Patients with hereditary polyposis syndromes.
- Patients with Lynch Syndrome.
- Patients with familial cancer. These criteria will ensure the probability of finding
polyps during the explorations.
All the patients will give written informed consent.
Exclusion Criteria:
- Patients at a high risk of having major complications as perforation or hemorrhage
or in whom the possibility of performing a complete colonoscopy is reduced,
including: patients with known colonic strictures, total or partial colectomy, acute
diverticulitis, abdominal surgery, inflammatory bowel disease, suspected or proven
lower gastrointestinal bleeding, non-correctable coagulopathy or
anticoagulant/clopidogrel therapy during procedure, inadequate bowel cleansing or
previous incomplete colonoscopy.
- ASA-IV patients.
- Urgent colonoscopy.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Hospital Clinic
Address:
City:
Barcelona
Country:
Spain
Status:
Recruiting
Contact:
Last name:
Glòria Fernández
Phone:
0034626710677
Email:
mgfernan@clinic.cat
Start date:
August 1, 2023
Completion date:
December 29, 2024
Lead sponsor:
Agency:
MiWEndo Solutions S.L.
Agency class:
Industry
Source:
MiWEndo Solutions S.L.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05988645